4.5 Article

HIV-2/SIV viral protein X counteracts HUSH repressor complex

Journal

NATURE MICROBIOLOGY
Volume 3, Issue 8, Pages 891-897

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41564-018-0179-6

Keywords

-

Categories

Funding

  1. Agence Nationale de la Recherche sur le SIDA et les hepatites virales (ANRS)
  2. SIDACTION
  3. Fondation de France
  4. Fondation pour la Recherche Medicale (FRM) [DEQ20140329528]
  5. French government
  6. amfAR (Mathilde Krim Phase II Fellowship) [109140-58-RKHF]
  7. Fondation pour la Recherche Medicale (FRM 'Projet Innovant') [ING20160435028]
  8. FINOVI ('Recently Settled Scientist' grant)
  9. ANRS [ECTZ19143]
  10. ANR LABEX ECOFECT (Universite de Lyon, within the programme 'Investissements d'Avenir' [ANR-11-LABX-0048, ANR-11-IDEX-0007]
  11. CNRS

Ask authors/readers for more resources

To evade host immune defences, human immunodeficiency viruses 1 and 2 (HIV-1 and HIV-2) have evolved auxiliary proteins that target cell restriction factors. Viral protein X (Vpx) from the HIV-2/SIVsmm lineage enhances viral infection by antagonizing SAMHD1 (refs(1,2)), but this antagonism is not sufficient to explain all Vpx phenotypes. Here, through a proteomic screen, we identified another Vpx target-HUSH (TASOR, MPP8 and periphilin)-a complex involved in position-effect variegation(3). HUSH downregulation by Vpx is observed in primary cells and HIV-2-infected cells. Vpx binds HUSH and induces its proteasomal degradation through the recruitment of the DCAF1 ubiquitin ligase adaptor, independently from SAMHD1 antagonism. As a consequence, Vpx is able to reactivate HIV latent proviruses, unlike Vpx mutants, which are unable to induce HUSH degradation. Although antagonism of human HUSH is not conserved among all lentiviral lineages including HIV-1, it is a feature of viral protein R (Vpr) from simian immunodeficiency viruses (SIVs) of African green monkeys and from the divergent SIV of l'Hoest's monkey, arguing in favour of an ancient lentiviral species-specific vpx/vpr gene function. Altogether, our results suggest the HUSH complex as a restriction factor, active in primary CD4(+) T cells and counteracted by Vpx, therefore providing a molecular link between intrinsic immunity and epigenetic control.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available